BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu M, Han S, Wang M, Han L, Huang Y, Bo P, Fang P, Zhang Z. Baicalin protects against insulin resistance and metabolic dysfunction through activation of GALR2/GLUT4 signaling. Phytomedicine 2021;95:153869. [PMID: 34923235 DOI: 10.1016/j.phymed.2021.153869] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Wolosowicz M, Prokopiuk S, Kaminski TW. Recent Advances in the Treatment of Insulin Resistance Targeting Molecular and Metabolic Pathways: Fighting a Losing Battle? Medicina 2022;58:472. [DOI: 10.3390/medicina58040472] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Zhang Y, Zhang Z, Zhang Y, Wu L, Gao L, Yao R, Zhang Y. Baicalin promotes the activation of brown and white adipose tissue through AMPK/PGC1α pathway. Eur J Pharmacol 2022;922:174913. [PMID: 35337814 DOI: 10.1016/j.ejphar.2022.174913] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]